Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gaine, Sean"" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Exploration of physical activity knowledge, preferences and support needs among pulmonary hypertension patients.
Autorzy:
McCormack C; School of Health & Human Performance, Dublin City University, Dublin, Ireland.; Department of Sport & Exercise Science, Waterford Institute of Technology, Waterford City, Ireland.; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Kehoe B; Department of Sport & Exercise Science, Waterford Institute of Technology, Waterford City, Ireland.
Cullivan S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
McCaffrey N; ExWell Medical, Dublin, Ireland.
Gaine S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
McCullagh B; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Moyna NM; School of Health & Human Performance, Dublin City University, Dublin, Ireland.
Hardcastle SJ; Department of Sport and Physical Activity, Sheffield Hallam University, Sheffield, United Kingdom.; Institute for Health Research, University of Notre Dame, Fremantle, Western Australia, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Jan 18; Vol. 18 (1), pp. e0277696. Date of Electronic Publication: 2023 Jan 18 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Quality of Life*
Hypertension, Pulmonary*/therapy
Adult ; Humans ; Middle Aged ; Exercise ; Exercise Therapy ; Ireland
Czasopismo naukowe
Tytuł:
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
Autorzy:
Rosenkranz S; Heart Center, University Hospital Cologne, and Cologne Cardiovascular Research Center (CCRC), Cologne, Germany.
Channick R; University of California Los Angeles, Los Angeles, CA, USA.
Chin KM; UT Southwestern Medical Center, Dallas, TX, USA.
Jenner B; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
Gaine S; Mater Misericordiae University Hospital, Dublin, Ireland.
Galiè N; DIMES, University of Bologna and IRCCS, S. Orsola University Hospital, Bologna, Italy.
Ghofrani HA; University of Giessen and Marburg Lung Center, Giessen, Germany, member of the German Center for Lung Research, and Department of Medicine, Imperial College London, London, UK.
Hoeper MM; Department of Respiratory Medicine, Hannover Medical School and German Center for Lung Research, Hannover, Germany.
McLaughlin VV; University of Michigan, Ann Arbor, MI, USA.
Du Roure C; Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
Rubin LJ; Division of Pulmonary and Critical Care Medicine, University of California, San Diego, CA, USA.
Sitbon O; Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.
Tapson V; Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Lang IM; Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jan; Vol. 24 (1), pp. 205-214. Date of Electronic Publication: 2021 Nov 21.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Heart Failure*/epidemiology
Hypertension, Pulmonary*/drug therapy
Hypertension, Pulmonary*/epidemiology
Pulmonary Arterial Hypertension*
Acetamides ; Antihypertensive Agents ; Comorbidity ; Double-Blind Method ; Humans ; Pyrazines
Czasopismo naukowe
Tytuł:
COVID-19 induces a hyperactive phenotype in circulating platelets.
Autorzy:
Comer SP; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Cullivan S; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Szklanna PB; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Weiss L; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Cullen S; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Kelliher S; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.
Smolenski A; School of Medicine, University College Dublin, Dublin, Ireland.
Murphy C; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; Department of Paediatrics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Altaie H; SAS UK Headquarters, Wittington House, Henley Road, Medmenham, Marlow, Buckinghamshire, United Kingdom.
Curran J; SAS Institute Ltd, Dublin, Ireland.
O'Reilly K; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.
Cotter AG; School of Medicine, University College Dublin, Dublin, Ireland.; UCD Centre for Experimental Pathogen and Host Research, Dublin, Ireland.; Department of Infectious Diseases, Mater Misericordiae University Hospital, Dublin, Ireland.
Marsh B; School of Medicine, University College Dublin, Dublin, Ireland.; Department of Critical Care Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Gaine S; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.
Mallon P; School of Medicine, University College Dublin, Dublin, Ireland.; Department of Infectious Diseases, St Vincent's University Hospital, Dublin, Ireland.
McCullagh B; Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.
Moran N; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Ní Áinle F; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.; Department of Haematology, Rotunda Hospital, Dublin, Ireland.
Kevane B; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; Department of Haematology, Mater Misericordiae University Hospital, Dublin, Ireland.; School of Medicine, University College Dublin, Dublin, Ireland.
Maguire PB; Conway SPHERE Research Group, Conway Institute, University College Dublin, Dublin Ireland.; School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.; UCD Institute for Discovery, University College Dublin, Dublin, Ireland.
Pokaż więcej
Corporate Authors:
COCOON Study investigators
Źródło:
PLoS biology [PLoS Biol] 2021 Feb 17; Vol. 19 (2), pp. e3001109. Date of Electronic Publication: 2021 Feb 17 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Platelets/*virology
COVID-19/*blood
Adenosine Triphosphate/metabolism ; Aged ; Blood Coagulation ; Blood Platelets/cytology ; Enzyme-Linked Immunosorbent Assay ; Female ; Hemostasis ; Humans ; Inflammation ; Intensive Care Units ; Male ; Mean Platelet Volume ; Middle Aged ; P-Selectin/blood ; Phenotype ; Platelet Factor 4/blood ; Platelet Function Tests ; Thrombopoietin/blood
Czasopismo naukowe
Tytuł:
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Autorzy:
Cohen AT; 1Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Ay C; 2Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hainaut P; 3Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium.
Décousus H; 4Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest En Jarez, France.
Hoffmann U; Division of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Gaine S; 6National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Coppens M; 7Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
da Silva PM; 8Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal.
Jimenez D; 9Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain.
Amann-Vesti B; 10Division of Angiology, University Hospital Zurich, Zurich, Switzerland.
Brüggenjürgen B; 11Institute for Health Economics, Steinbeis-University, Berlin, Germany.
Levy P; 12LEGOS, Université Paris - Dauphine, Paris, France.
Bastida JL; 13University of Castilla-La Mancha, Talavera de la Reina, Toledo Spain.
Vicaut E; 14Department of Medicine, Université Paris Descartes, Paris, France.
Laeis P; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Fronk EM; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Zierhut W; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Malzer T; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Bramlage P; Institute for Pharmacology and Preventive Medicine, Berlin, Germany.
Agnelli G; 17Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
Pokaż więcej
Corporate Authors:
ETNA-VTE-Europe investigators
Źródło:
Thrombosis journal [Thromb J] 2018 May 31; Vol. 16, pp. 18. Date of Electronic Publication: 2018 May 31 (Print Publication: 2018).
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study.
Autorzy:
Cohen AT; 1Guy's and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Ay C; 2Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
Hainaut P; 3Department of General Internal Medicine, Cliniques Universitaires Saint Luc, UCL, Bruxelles, Belgium.
Décousus H; 4Centre Hospitalier Universitaire de Saint-Etienne, Saint-Priest En Jarez, France.
Hoffmann U; Division of Angiology, Medical Clinic IV, University Hospital, Ludwig-Maximilians-University, Munich, Germany.
Gaine S; 6National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.
Coppens M; 7Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
da Silva PM; 8Department of Internal Medicine, Arterial Investigation Unit, Hospital de Santa Marta, Lisbon, Portugal.
Castro DJ; 9Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain.
Amann-Vesti B; 10Division of Angiology, University Hospital Zurich, Zurich, Switzerland.
Brüggenjürgen B; 11Institute for Health Economics, Steinbeis-University, Berlin, Germany.
Levy P; 12LEGOS, Université Paris - Dauphine, Paris, France.
Bastida JL; 13University of Castilla-La Mancha, Talavera de la Reina, Toledo, Spain.
Vicaut E; 14Department of Medicine, Université Paris Descartes, Paris, France.
Laeis P; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Fronk EM; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Zierhut W; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Malzer T; 15Daiichi Sankyo Europe GmbH, Munich, Germany.
Bramlage P; Institute for Pharmacology and Preventive Medicine, Berlin, Germany.
Agnelli G; 17Internal and Cardiovascular Medicine-Stroke Unit, University of Perugia, Perugia, Italy.
Pokaż więcej
Corporate Authors:
ETNA-VTE-Europe investigators
Źródło:
Thrombosis journal [Thromb J] 2018 May 01; Vol. 16, pp. 9. Date of Electronic Publication: 2018 May 01 (Print Publication: 2018).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Elevated plasma CXCL12α is associated with a poorer prognosis in pulmonary arterial hypertension.
Autorzy:
McCullagh BN; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Costello CM; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
Li L; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
O'Connell C; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Codd M; School of Public Health, Physiotherapy and Population Science, University College Dublin, Dublin 4, Ireland.
Lawrie A; Department of Cardiovascular Sciences, University of Sheffield, Sheffield, United Kingdom.
Morton A; Department of Cardiology, Northern General Hospital, Sheffield, United Kingdom.
Kiely DG; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Condliffe R; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
Elliot C; Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.
McLoughlin P; School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Dublin 4, Ireland.
Gaine S; Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin 7, Ireland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Apr 09; Vol. 10 (4), pp. e0123709. Date of Electronic Publication: 2015 Apr 09 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prognosis*
Chemokine CXCL12/*blood
Familial Primary Pulmonary Hypertension/*blood
Adult ; Aged ; Blood Pressure ; Familial Primary Pulmonary Hypertension/epidemiology ; Familial Primary Pulmonary Hypertension/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Pulmonary Artery/metabolism ; Pulmonary Artery/pathology
Czasopismo naukowe
Tytuł:
Right heart and pulmonary vessels structure and function.
Autorzy:
D'Alto M; Department of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.
Scognamiglio G
Dimopoulos K
Bossone E
Vizza D
Romeo E
Vonk-Noordergraaf A
Gaine S
Peacock A
Naeije R
Pokaż więcej
Źródło:
Echocardiography (Mount Kisco, N.Y.) [Echocardiography] 2015 Jan; Vol. 32 Suppl 1, pp. S3-10. Date of Electronic Publication: 2014 Sep 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Stroke Volume*
Heart Ventricles/*anatomy & histology
Heart Ventricles/*embryology
Hypertension, Pulmonary/*physiopathology
Ventricular Remodeling/*physiology
Adult ; Female ; Heart Atria/physiopathology ; Heart Defects, Congenital/physiopathology ; Humans ; Male ; Myocardial Contraction/physiology ; Pulmonary Artery/physiopathology ; Pulmonary Circulation/physiology ; Role ; Ventricular Function, Right/physiology
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies